FIELD: medicine, pharmaceutics.
SUBSTANCE: disclosed is ibuprofene chewing tablet of direct pressing with masked taste. Ibuprofene chewing tablet contains therapeutically effective quantity of ibuprofene and pharmaceutically acceptable carrier, where ibuprofene has the average size of particles from 250 mcm to 400 mcm.
EFFECT: invention provides possibility of effective masking ibuprofene bitter taste.
10 cl, 6 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PER ORALLY DECOMPOSING TABLET COMPOSITIONS, CONTAINING COMBINATIONS OF NON-OPIATE ANALGESICS | 2010 |
|
RU2567032C2 |
| COMPOSITIONS OF ORALLY DISPERSIBLE TABLETS CONTAINING COMBINATIONS OF HIGH- AND LOW-DOSE THERAPEUTIC AGENTS | 2010 |
|
RU2554740C2 |
| SOLID OR SEMI-LIQUID TIME-RELEASE DOSAGE FORMS | 2008 |
|
RU2471480C2 |
| DOSAGE FORM OF ORALLY DISINTEGRATING TWO-PIECE TABLET | 2008 |
|
RU2466719C2 |
| PRODUCING TABLET BY MEANS OF PRESS MOULD USING RADIO-FREQUENCY RADIATION AND FUSIBLE BINDING AGENT | 2010 |
|
RU2545989C2 |
| PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION WITH MASKED TASTE AND PREPARATION METHOD THEREOF | 2012 |
|
RU2583935C2 |
| IBUPROFEN DOSED FORM | 1997 |
|
RU2182000C2 |
| SOLID DOSED OUT FORM OF SIMETHICON FOR PERORAL APPLICATION | 2002 |
|
RU2362569C2 |
| CHEWING TABLET CONTAINING LYSINE | 2002 |
|
RU2324474C2 |
| SOLID MEDICINAL FORM FOR ORAL ADMINISTRATION OF PHARMACEUTICALLY ACTIVE SUBSTANCES SHOWING UNFAVORABLE ORGANOLEPTIC PROPERTIES | 1991 |
|
RU2085190C1 |
